These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 15696596)

  • 1. Inhibition of angiogenesis-relevant receptor tyrosine kinases by sulindac analogues.
    Gourzoulidou E; Carpintero M; Baumhof P; Giannis A; Waldmann H
    Chembiochem; 2005 Mar; 6(3):527-31. PubMed ID: 15696596
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitors of angiogenesis and cancer-related receptor tyrosine kinases.
    Mazitschek R; Giannis A
    Curr Opin Chem Biol; 2004 Aug; 8(4):432-41. PubMed ID: 15288254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 3-substituted-2-oxoindole analogues and their evaluation as kinase inhibitors, anticancer and antiangiogenic agents.
    Abadi AH; Abou-Seri SM; Abdel-Rahman DE; Klein C; Lozach O; Meijer L
    Eur J Med Chem; 2006 Mar; 41(3):296-305. PubMed ID: 16494969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-substituted, 2,4-diaminofuro[2,3-d]pyrimidines as multireceptor tyrosine kinase and dihydrofolate reductase inhibitors with antiangiogenic and antitumor activity.
    Gangjee A; Zeng Y; Ihnat M; Warnke LA; Green DW; Kisliuk RL; Lin FT
    Bioorg Med Chem; 2005 Sep; 13(18):5475-91. PubMed ID: 16039863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A concise synthesis of a novel antiangiogenic tyrosine kinase inhibitor.
    Payack JF; Vazquez E; Matty L; Kress MH; McNamara J
    J Org Chem; 2005 Jan; 70(1):175-8. PubMed ID: 15624920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and biological evaluation of 3,4-diarylmaleimides as angiogenesis inhibitors.
    Peifer C; Stoiber T; Unger E; Totzke F; Schächtele C; Marmé D; Brenk R; Klebe G; Schollmeyer D; Dannhardt G
    J Med Chem; 2006 Feb; 49(4):1271-81. PubMed ID: 16480264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of anti-angiogenic tyrosine kinases inhibitors: molecular structures and binding modes.
    Zhang J; Zhang L; Wang Y; Zhao G
    Cancer Chemother Pharmacol; 2016 May; 77(5):905-26. PubMed ID: 26781310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, discovery and preliminary SAR study of benzofuran derivatives as angiogenesis inhibitors.
    Chen Y; Chen S; Lu X; Cheng H; Ou Y; Cheng H; Zhou GC
    Bioorg Med Chem Lett; 2009 Apr; 19(7):1851-4. PubMed ID: 19272775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-(Azolyl)-4-(aryl)-phthalazines: novel potent inhibitors of VEGF receptors I and II.
    Kiselyov AS; Semenova M; Semenov VV; Piatnitski EL
    Chem Biol Drug Des; 2006 Nov; 68(5):250-5. PubMed ID: 17177884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaffold oriented synthesis. Part 2: Design, synthesis and biological evaluation of pyrimido-diazepines as receptor tyrosine kinase inhibitors.
    Gracias V; Ji Z; Akritopoulou-Zanze I; Abad-Zapatero C; Huth JR; Song D; Hajduk PJ; Johnson EF; Glaser KB; Marcotte PA; Pease L; Soni NB; Stewart KD; Davidsen SK; Michaelides MR; Djuric SW
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2691-5. PubMed ID: 18362070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isothiazolopyrimidines and isoxazolopyrimidines as novel multi-targeted inhibitors of receptor tyrosine kinases.
    Ji Z; Ahmed AA; Albert DH; Bouska JJ; Bousquet PF; Cunha GA; Glaser KB; Guo J; Li J; Marcotte PA; Moskey MD; Pease LJ; Stewart KD; Yates M; Davidsen SK; Michaelides MR
    Bioorg Med Chem Lett; 2006 Aug; 16(16):4326-30. PubMed ID: 16735117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-angiogenic activity of basic-type, selective cyclooxygenase (COX)-1 inhibitors.
    Sano H; Noguchi T; Miyajima A; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2006 Jun; 16(11):3068-72. PubMed ID: 16513348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide inhibitors of G protein-coupled receptor kinases.
    Winstel R; Ihlenfeldt HG; Jung G; Krasel C; Lohse MJ
    Biochem Pharmacol; 2005 Oct; 70(7):1001-8. PubMed ID: 16102734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid construction of the cortistatin pentacyclic core.
    Simmons EM; Hardin AR; Guo X; Sarpong R
    Angew Chem Int Ed Engl; 2008; 47(35):6650-3. PubMed ID: 18637646
    [No Abstract]   [Full Text] [Related]  

  • 15. Synthesis and anti-angiogenesis activity of coumarin derivatives.
    Lee S; Sivakumar K; Shin WS; Xie F; Wang Q
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4596-9. PubMed ID: 16793260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Hydroxy-4,6-diamino-[1,3,5]triazines: a novel class of VEGF-R2 (KDR) tyrosine kinase inhibitors.
    Baindur N; Chadha N; Brandt BM; Asgari D; Patch RJ; Schalk-Hihi C; Carver TE; Petrounia IP; Baumann CA; Ott H; Manthey C; Springer BA; Player MR
    J Med Chem; 2005 Mar; 48(6):1717-20. PubMed ID: 15771417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of novel curcumin mimics with asymmetrical units and their anti-angiogenic activity.
    Woo HB; Shin WS; Lee S; Ahn CM
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3782-6. PubMed ID: 15993583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hybrid angiogenesis inhibitors: synthesis and biological evaluation of bifunctional compounds based on 1-deoxynojirimycin and aryl-1,2,3-triazoles.
    Zhou Y; Zhao Y; O' Boyle KM; Murphy PV
    Bioorg Med Chem Lett; 2008 Feb; 18(3):954-8. PubMed ID: 18166456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain.
    Wilkinson B; Gregory MA; Moss SJ; Carletti I; Sheridan RM; Kaja A; Ward M; Olano C; Mendez C; Salas JA; Leadlay PF; vanGinckel R; Zhang MQ
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5814-7. PubMed ID: 16962775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, pharmacological evaluation and docking studies of new sulindac analogues.
    Romeiro NC; Leite RD; Lima LM; Cardozo SV; de Miranda AL; Fraga CA; Barreiro EJ
    Eur J Med Chem; 2009 May; 44(5):1959-71. PubMed ID: 19144452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.